Dentsply Sirona (XRAY)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · XRAY
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition On August 6, 2026, DENTSPLY SIRONA Inc. (the “Company”) issued a press release regarding the Company’s financial results for its second fiscal quarter ended June 30, 2026. A copy of the Company’s press release is furnished as Exhibit 99.1. The information contained in this Current Report on Form 8-K pursuant to Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amend…
Results of Operations and Financial Condition On August 6, 2026, DENTSPLY SIRONA Inc. (the “Company”) issued a press release regarding the Company’s financial results for its second fiscal quarter ended June 30, 2026. A copy of the Company’s press release is furnished as Exhibit 99.1. The information contained in this Current Report on Form 8-K pursuant to Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amend…
Executive Vice President & Chief Financial Officer — John C. Fortson: The company hired a new Chief Financial Officer from an external position.
Results of Operations and Financial Condition On May 5, 2026, DENTSPLY SIRONA Inc. (the “Company”) issued a press release regarding the Company’s financial results for its first fiscal quarter ended March 31, 2026. A copy of the Company’s press release is furnished as Exhibit 99.1 and an updated GAAP to Non-GAAP reconciliation is furnished as Exhibit 99.2. The information contained in this Current Report on Form 8-K pursuant to Item 2.02, including Exhibit 99.1 and 99.2, shall not be deemed “…
Results of Operations and Financial Condition On February 26, 2026, DENTSPLY SIRONA Inc. (the “Company”) issued a press release regarding the Company’s financial results for its fourth fiscal quarter and year ended December 31, 2025. A copy of the Company’s press release is furnished as Exhibit 99.1. The information contained in this Current Report on Form 8-K pursuant to Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act o…
Director — Messrs. James D. Forbes and Brian P. McKeon: The Board appointed two new directors to the board, increasing its size from 11 to 13.
Director — Donald J. Zurbay: The filing discloses the appointment of a new director to an expanded board, which is a routine governance action and not a departure of a senior executive.
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant The information set forth in
Entry Into a Material Definitive Agreement On December 24, 2025, DENTSPLY SIRONA Inc. (the “Company”) obtained the consent of the requisite lenders under its revolving credit facility, dated May 12, 2023, with JPMorgan Chase Bank, N.A., as administrative agent, to, among other things, amend certain provisions by entering into the Second Amendment to Credit Agreement, dated as of December 24, 2025 (the “Second Amendment to Credit Agreement”). On December 24, 2025, the Company entered into the…
CFO — Matthew E. Garth: The CFO is ceasing service with a separation agreement and no immediate successor named, indicating a genuine executive departure.
Results of Operations and Financial Condition On November 6, 2025, DENTSPLY SIRONA Inc. (the “Company”) issued a press release regarding the Company’s financial results for its third fiscal quarter ended September 30, 2025. A copy of the Company’s press release is furnished as Exhibit 99.1. The information contained in this Current Report on Form 8-K pursuant to Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as…
CFO — Matthew E. Garth: The CFO is departing without a permanent successor, requiring the CEO to serve as interim PFO, which signals a significant leadership gap.
Other Events On October 14, 2025, DENTSPLY SIRONA Inc. (the “Company”) announced that the Division of Enforcement of the Securities and Exchange Commission (the “SEC”) has concluded its investigation of the Company commenced in May 2022 (the “SEC Investigation”) and does not intend to recommend any enforcement action against the Company. The SEC Investigation related to the Company’s investigation led by the Audit and Finance Committee, initiated in March 2022, into allegations regarding cert…
Executive Vice President, Corporate Development, General Counsel and Secretary — Richard C. Rosenzweig: Mr. Rosenzweig will transition to a Special Legal Advisor role and then become an independent contractor consultant.
Chief Supply Chain Officer — Tony Johnson: The filing discloses a retention equity award to an executive, which is a compensatory arrangement rather than a departure, appointment, or board election.
Results of Operations and Financial Condition On August 7, 2025, DENTSPLY SIRONA Inc. (the “Company”) issued a press release regarding the Company’s financial results for its second fiscal quarter ended June 30, 2025. A copy of the Company’s press release is furnished as Exhibit 99.1. The information contained in this Current Report on Form 8-K pursuant to Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amend…
CEO — Simon D. Campion: The CEO is departing with a named, highly qualified successor (Daniel T. Scavilla) already appointed, indicating an orderly succession rather than a sudden loss of leadership.
Results of Operations and Financial Condition On July 21, 2025, DENTSPLY SIRONA Inc. (the “Company”) issued a press release announcing select preliminary financial results for the three months ended June 30, 2025, reaffirming its 2025 outlook, and announcing the leadership changes described below in
Termination of a Material Definitive Agreement On June 12, 2025, the Company used a portion of the proceeds from the Notes Offering to repay in full the outstanding principal and accrued interest due under the Company’s existing 364-day $435 million term loan (the “Bridge Loan Facility”). As a result of this repayment, the Bridge Loan Facility has been terminated (together with the agreements and instruments related thereto), and no additional interest or fees will accrue in respect of the Br…
Entry into a Material Definitive Agreement On June 12, 2025, DENTSPLY SIRONA Inc. (the “Company”) issued $550,000,000 aggregate principal amount of the Company’s 8.375% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2055 (the “Notes). The Notes were issued pursuant to the Company’s Registration Statement on Form S-3ASR, File No. 333-286281, dated March 31, 2025 (the “Notes Offering”). The Notes were issued under an Indenture, dated May 26, 2020 (the “Base Indenture”), between the Com…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant The disclosure provided in
Other Events On June 5, 2025, DENTSPLY SIRONA Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC, as representative of the several underwriters named in Schedule II thereto (collectively, the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $550,000,000 aggregate principal amount of its 8.375% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2055 (the “Notes”), for resale to…
Entry Into a Material Definitive Agreement On June 3, 2025, DENTSPLY SIRONA Inc. (the “Company”) obtained the consent of the requisite lenders under its revolving credit facility, dated May 12, 2023, with JPMorgan Chase Bank, N.A., as administrative agent, to, among other things, amend certain provisions by entering into the First Amendment to Credit Agreement, dated as of June 3, 2025 (the “First Amendment to Credit Agreement”). On June 3, 2025, the Company entered into the following agreeme…
CFO — Matthew E. Garth: The filing announces the appointment of an external candidate as the new Executive Vice President & Chief Financial Officer, which is a significant management change but not a departure event.
Results of Operations and Financial Condition On May 8, 2025, DENTSPLY SIRONA Inc. (the “Company”) issued a press release regarding the Company’s financial results for its first fiscal quarter ended March 31, 2025. A copy of the Company’s press release is furnished as Exhibit 99.1. The information contained in this Current Report on Form 8-K pursuant to Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.